FindTrial
Sign In

Comparing the Add on Effectiveness of Intra-Articular Injections of High Molecular Weight Hyaluronic Acid (Viscor®>2000 KD) with Low Molecular Weight Hyaluronic Acid (Hyalgan® MW= 500-800 KD) and Lidocaine In Frozen Shoulder Conventional Physical Therapy.

Evaluating the Efficacy and Safety of adding Intra- Articular High Molecular Weight Hyaluronic Acid (Viscor® MW>2000 KD) Injections in Comparison of Low Molecular Weight Hyaluronic Acid (Hyalgan® MW= 500-800 KD) and lidocaine In Idiopathic Adhesive Capsulitis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170608034390N4
Enrollment
50
Registered
2020-01-01
Start date
2018-11-22
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Adhesive Capsulitis (Frozen Shoulder). Adhesive capsulitis of unspecified shoulder

Interventions

Intervention 1: Intervention group: One arm revived intra-articular injection of High Molecular Weight hyaluronic acid (Viscor® >2000 KD) in shoulder joint adding to the conventional physical therapy.

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Adults (>18 years) Less than 65 years old It takes less than three month from the onset of the disorder

Exclusion criteria

Exclusion criteria: History of Traumatic Injury to the shoulder Active Tendonitis History of rotator cuff tear History of NSAIDs use during the last week History of systemic corticosteroid use during the last 1 month

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: At baseline, 4, 12 and 24 weeks after injection. Method of measurement: Visual Analog Scale.—

Secondary

MeasureTime frame
Range of Motion. Timepoint: At baseline, 4 and 12 weeks after injection. Method of measurement: Goniometry.;Inflammation Signs and Symptoms. Timepoint: at baseline of injection. Method of measurement: Hyperemia, Warmly, Pain, Tendonitis, Tenderness.;Oxford Shoulder Score. Timepoint: At baseline, 4 and 12 weeks after injection. Method of measurement: Oxford Questionnaire.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHadi Esmaily

Shahid Beheshti University of Medical Sciences

Esmaily_hadi@sbmu.ac.ir+98 211579064

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026